Hervor Therapeutics
Clinical trials sponsored by Hervor Therapeutics, explained in plain language.
-
Doctors test re-engineered immune cells to fight advanced cancers
Disease control TerminatedThis early-stage trial tested a personalized treatment called Tumor-Infiltrating Lymphocyte (TIL) therapy for adults with advanced solid tumors that hadn't responded to standard treatments. Doctors collected immune cells from a patient's own tumor, grew large numbers of them in a…
Phase: PHASE1 • Sponsor: Hervor Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Personalized cancer cell therapy trial halted after single patient
Disease control TerminatedThis early-stage study tested a personalized cell therapy called HV-101 for adults with advanced solid tumors that had returned or spread. Doctors planned to extract immune cells from a patient's own tumor, grow them in a lab, and reinfuse them to fight the cancer. The trial was …
Phase: PHASE1 • Sponsor: Hervor Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC